Nkarta Reports First Quarter 2023 Financial Results and
Clinical updates on track for NKX101 in second quarter of 2023 at a company-hosted event and NKX019 in second half of 2023Cash and cash equivalents of...
Source: globenewswire.com
Page 3 - Clinical Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Program Updates Today - Breaking & Trending Today
Tiziana Life Sciences Ltd Reports Annual Results for the Twelve Months Ended December 31, 2022, and Corporate Update
Recognized standard clinical outcome assessment. In March: Tiziana announced a publication in the preeminent1 journal, Proceedings of the National Academy of Sciences , that... | April 26, 2023
Source: marketscreener.com
Tiziana Life Sciences Ltd.: Tiziana Life Sciences Ltd Reports Annual Results for the Twelve Months Ended December 31, 2022, and Corporate Update
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel
Source: finanznachrichten.de
Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate Outlook
Type B end-of-Phase 2 meeting with U.S. Food and Drug Administration provided additional clarity for TSHA-120 for the treatment of giant axonal neuropathy ultra-rare disease program - FDA... | January 31, 2023
Source: marketscreener.com
Surface Oncology to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
– SRF388 demonstrated clinical activity in multiple solid tumor types withthree confirmed partial responses across NSCLC, RCC and HCC – – Data support continued evaluation of SRF388... | May 26, 2022
Source: marketscreener.com